What Should All Physicians Know About Endovascular Stroke Care?

December 4, 2020
Endovascular stroke care is the criterion standard for LVO treatment, yet not everyone is fluent with data and techniques.  
0 Comments

Emergency Nursing Assessments, the NIHSS and Pitfalls in Identifying Acute Stroke Patients. How Do You Do It, and Do It Well?

December 4, 2020
Nurses in the emergency setting are the key to stroke patient progression. From first point of assessment and triage, ED nurses set the standard. 
0 Comments

What Pitfalls Do Clinicians Face In Understanding Statistics In Acute Stroke Trials?

December 4, 2020
Statistics can illuminate or obfuscate. Clinicians need to understand acute stroke trial data and statistics in meaningful ways, but challenges abound.
1 Comments

What Was Missing From the NINDS Trial?

December 4, 2020
The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the interpretation of the data. Was anything missing from NINDS? Does it still resonate nearly 25 years later?
0 Comments

Mobile Stroke Units - Linking Ultra Early Care and Outcomes

December 2, 2020
Imagine a mobile stroke unit, with a CT scanner, arriving to care for stroke patients at the first point of medical contact. What are the possibilities and what are the data?
0 Comments
RSS
First123456810
Categories
More Entries

Dec 2

When Might You Use Heparin in the NeuroICU for a Stroke Patient?

Brian Gibler posted on 12/2/2020

Moderator:William A. Knight IV, MD, FACEP, FNCS
Other Participants: Kyle B. Walsh, MD, MS

Heparin in stroke remains controversial. Understanding the history and data and essential to mastering stroke care.

Dr. Kyle Walsh, an Emergency Medicine trained Neurointensivist, researcher and stroke physician shares his expertise with Dr. Bill Knight as they discuss heparin in stroke care. Not all heparin is bad,  but its use has been deemphasized over the years.  What are the data and how do they inform the use of heparin in acute stroke? Moreover, is heparin in acute ischemic stroke really dead?

0 Comments
Tweet Share
Please login or register to post comments.
STAY CONNECTED
Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.
@stroke_journey
ABOUT THE STROKE JOURNEY
The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.
OUR PARTNERS
The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.
NSEC Sponsor Logo
EMREG Sponsor Logo
MedEd Sponsor Logo
Copyright 2024 The Stroke Journey | Privacy Policy | Terms of Use | Help & Support
Copyright 2024 The Stroke Journey
Privacy Policy | Terms of Use | Help & Support
Powered by MedEdOTG.com